Jeffrey E. Russel

Array ( [id] => 3615844 [patent_doc_number] => 05510466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Scavenger receptor protein and antibody thereto' [patent_app_type] => 1 [patent_app_number] => 8/307400 [patent_app_country] => US [patent_app_date] => 1994-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 9376 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510466.pdf [firstpage_image] =>[orig_patent_app_number] => 307400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682368 [patent_doc_number] => 05633227 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Secretory leukocyte protease inhibitor as an inhibitor of tryptase' [patent_app_type] => 1 [patent_app_number] => 8/304051 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 12744 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633227.pdf [firstpage_image] =>[orig_patent_app_number] => 304051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3507477 [patent_doc_number] => 05514773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Depsipeptide derivatives, production thereof and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/295782 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31237 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514773.pdf [firstpage_image] =>[orig_patent_app_number] => 295782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3505655 [patent_doc_number] => 05514653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Method of blocking the SEC receptor' [patent_app_type] => 1 [patent_app_number] => 8/306872 [patent_app_country] => US [patent_app_date] => 1994-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514653.pdf [firstpage_image] =>[orig_patent_app_number] => 306872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3816387 [patent_doc_number] => 05770565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Peptides for reducing or inhibiting bone resorption' [patent_app_type] => 1 [patent_app_number] => 8/303052 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 25111 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770565.pdf [firstpage_image] =>[orig_patent_app_number] => 303052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665219 [patent_doc_number] => 05597796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Transdermal insulin' [patent_app_type] => 1 [patent_app_number] => 8/301838 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7236 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597796.pdf [firstpage_image] =>[orig_patent_app_number] => 301838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510147 [patent_doc_number] => 05563122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Stabilized parathyroid hormone composition' [patent_app_type] => 1 [patent_app_number] => 8/244758 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2434 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563122.pdf [firstpage_image] =>[orig_patent_app_number] => 244758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724327 [patent_doc_number] => 05700648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Streptolysin O antigen derivatives, their production and uses' [patent_app_type] => 1 [patent_app_number] => 8/296879 [patent_app_country] => US [patent_app_date] => 1994-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5138 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700648.pdf [firstpage_image] =>[orig_patent_app_number] => 296879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643430 [patent_doc_number] => 05628993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Sustained releasable parenteral pharmaceutical preparations and method of producing the same' [patent_app_type] => 1 [patent_app_number] => 8/294972 [patent_app_country] => US [patent_app_date] => 1994-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5161 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/628/05628993.pdf [firstpage_image] =>[orig_patent_app_number] => 294972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622078 [patent_doc_number] => 05593964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method of treating septic shock by preventing actin polymerization' [patent_app_type] => 1 [patent_app_number] => 8/292757 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3320 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593964.pdf [firstpage_image] =>[orig_patent_app_number] => 292757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3535097 [patent_doc_number] => 05556941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds' [patent_app_type] => 1 [patent_app_number] => 8/291729 [patent_app_country] => US [patent_app_date] => 1994-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9078 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556941.pdf [firstpage_image] =>[orig_patent_app_number] => 291729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3492149 [patent_doc_number] => 05440019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'Processes of producing amylase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/286176 [patent_app_country] => US [patent_app_date] => 1994-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4824 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/440/05440019.pdf [firstpage_image] =>[orig_patent_app_number] => 286176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3538779 [patent_doc_number] => 05480782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Process for obtaining cellular protein having anti-HIV activity' [patent_app_type] => 1 [patent_app_number] => 8/285437 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480782.pdf [firstpage_image] =>[orig_patent_app_number] => 285437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687956 [patent_doc_number] => 05643881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Protein having anti-HIV activity and method for obtaining it' [patent_app_type] => 1 [patent_app_number] => 8/285436 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3927 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643881.pdf [firstpage_image] =>[orig_patent_app_number] => 285436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612363 [patent_doc_number] => 05565430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Azaaspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/284861 [patent_app_country] => US [patent_app_date] => 1994-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4057 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565430.pdf [firstpage_image] =>[orig_patent_app_number] => 284861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3524671 [patent_doc_number] => 05527772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Regulation of cell proliferation and differentiation using peptides' [patent_app_type] => 1 [patent_app_number] => 8/281648 [patent_app_country] => US [patent_app_date] => 1994-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6614 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527772.pdf [firstpage_image] =>[orig_patent_app_number] => 281648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3826844 [patent_doc_number] => 05783558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Parathormone fragments, their preparation and medicaments containing these' [patent_app_type] => 1 [patent_app_number] => 8/256363 [patent_app_country] => US [patent_app_date] => 1994-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783558.pdf [firstpage_image] =>[orig_patent_app_number] => 256363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3530076 [patent_doc_number] => 05583101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction' [patent_app_type] => 1 [patent_app_number] => 8/276105 [patent_app_country] => US [patent_app_date] => 1994-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6022 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583101.pdf [firstpage_image] =>[orig_patent_app_number] => 276105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688188 [patent_doc_number] => 05696116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Pharmaceutical composition which contains a renin angiotensin system inhibitor and an endothelin antagonist' [patent_app_type] => 1 [patent_app_number] => 8/273663 [patent_app_country] => US [patent_app_date] => 1994-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4684 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696116.pdf [firstpage_image] =>[orig_patent_app_number] => 273663 [rel_patent_id] =>[rel_patent_doc_number] =>)